Somatic mutations of the catalytic subunit of cyclic AMP dependent protein kinase (PRKACA) gene in Japanese patients with several adrenal adenomas secreting cortisol

Endocrine Journal

Volumn 61, Issue 8, 2014, Pages 825-832

  Nakajima, Yasuyo ^a   Okamura, Takashi ^a   Gohko, Tamae ^a   Satoh, Tetsurou ^a   Hashimoto, Koshi ^a   Shibusawa, Nobuyuki ^a   Ozawa, Atsushi ^a   Ishii, Sumiyasu ^a   Tomaru, Takuya ^a   Horiguchi, Kazuhiko ^a   Okada, Shuichi ^a   Yamada, Masanobu ^a   Takata, Daisuke ^a   Rokutanda, Nana ^a   Horiguchi, Jun ^a   Takeyoshi, Izumi ^a   Tsushima, Yoshito ^a   Oyama, Tetsunari ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cortisol producing adenomas; Japanese; PRKACA

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT; HYDROCORTISONE; PRKACA PROTEIN, HUMAN;

ADRENAL CORTEX ADENOMA; ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; CUSHING SYNDROME; FEMALE; GENE; GENE MUTATION; HUMAN; HYDROCORTISONE RELEASE; JAPAN; JAPANESE (PEOPLE); KCNJ5 GENE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIMARY HYPERALDOSTERONISM; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SOMATIC MUTATION; UNIVERSITY HOSPITAL; WILD TYPE; ADENOMA; ADRENAL GLAND NEOPLASMS; GENETICS; MIDDLE AGED; MUTATION; NEOPLASMS, MULTIPLE PRIMARY; RETROSPECTIVE STUDY; SECRETION (PROCESS);

ADENOMA; ADRENAL GLAND NEOPLASMS; ADULT; AGED; CUSHING SYNDROME; CYCLIC AMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNITS; FEMALE; HUMANS; HYDROCORTISONE; JAPAN; MIDDLE AGED; MUTATION; NEOPLASMS, MULTIPLE PRIMARY; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RETROSPECTIVE STUDIES;

EID: 84906827864     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ14-0282     Document Type: Article

References (22)

1. Nieman L, Biller B, Findling J, Newell-Price J, Savage M, et al. (2008) The diagnosis of Cushing’s syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 93: 1526-1540.
2. Newell-Price J, Bertagna X, Grossman AB, Nieman LK (2006) Cushing’s syndrome. Lancet 367: 1605-1617.
3. Rossi R, Tauchmanova L, Luciano A, Di Martino M, Battista C, et al. (2000) Subclinical Cushing’s syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J Clin Endocrinol Metab 85: 1440-1448.
4. Terzolo M, Reimondo G, Bovio S, Angeli A (2004) Subclinical Cushing’s syndrome. Pituitary 7: 217-223.
5. Grumbach M, Biller B, Braunstein G, Campbell K, Carney J, et al. (2003) Management of the clinically inapparent adrenal mass (“incidentaloma”). Ann Intern Med 138: 424-429.
6. Tsagarakis S, Vassiliadi D, Thalassinos N (2006) Endogenous subclinical hypercortisolism: Diagnostic uncertainties and clinical implications. J Endocrinol Invest 29: 471-482.
7. Nakajima Y, Yamada M, Taguchi R, Satoh T, Hashimoto K, et al. (2011) Cardiovascular complications of patients with aldosteronism associated with autonomous cortisol secretion. J Clin Endocrinol Metab 96: 2512-2518.
8. Adachi J, Hirai Y, Terui K, Nakano T, Fukuda Y, et al. (2003) A report of 7 cases of adrenal tumors secreting both cortisol and aldosterone. Intern Med 42: 714-718.
9. Späth M, Korovkin S, Antke C, Anlauf M, Willenberg HS (2011) Aldosterone-and cortisol-co-secreting adrenal tumors: the lost subtype of primary aldosteronism. Eur J Endocrinol 164: 447-455.
10. Beuschlein F, Fassnacht M, Assié G, Calebiro D, Stratakis CA, et al. (2014) Constitutive activation of PKA catalytic subunit in adrenal Cushing’s syndrome. N Engl J Med 370: 1019-1028.
11. Goh G, Scholl UI, Healy JM, Choi M, Prasad ML, et al. (2014) Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors. Nat Genet 46: 613-617.
12. Taguchi R, Yamada M, Nakajima Y, Satoh T, Hashimoto K, et al. (2012) Expression and Mutations of KCNJ5 mRNA in Japanese Patients with Aldosterone-Producing Adenomas. J Clin Endocrinol Metab 97: 1311-1319.
13. Yamada M, Nakajima Y, Taguchi R, Okamura T, Ishii S, et al. (2012) KCNJ5 mutations in aldosterone-and cortisol-co-secreting adrenal adenomas. Endocr J 59: 735-741.
14. Mulatero P, Monticone S, Rainey WE, Veglio F, Williams TA (2013) Role of KCNJ5 in familial and sporadic primary aldosteronism. Nat Rev Endocrinol 9: 104-112.
15. Funder J, Carey R, Fardella C, Gomez-Sanchez C, Mantero F, et al. (2008) Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 93: 3266-3281.
16. Hiraishi K, Yoshimoto T, Tsuchiya K, Minami I, Doi M, et al. (2011) Clinicopathological features of primary aldosteronism associated with subclinical Cushing’s syndrome. Endocr J 58: 543-551.
17. Ishida E, Yamada M, Horiguchi K, Taguchi R, Ozawa A, et al. (2011) Attenuated expression of menin and p27 (Kip1) in an aggressive case of multiple endocrine neoplasia type 1 (MEN1) associated with an atypical prolactinoma and a malignant pancreatic endocrine tumor. Endocr J 58: 287-296.
18. Cao Y, He M, Gao Z, Peng Y, Li Y, et al. (2014) Activating Hotspot L205R Mutation in PRKACA and Adrenal Cushing’s Syndrome. Science 344: 913-917.
19. Sato Y, Maekawa S, Ishii R, Sanada M, Morikawa T, et al. (2014) Recurrent somatic mutations underlie corticotropin-independent Cushing’s syndrome. Science 344: 917-920.
20. Chiodini I (2011) Clinical review: Diagnosis and treatment of subclinical hypercortisolism. J Clin Endocrinol Metab 96: 1223-1236.
21. Barzon L, Sonino N, Fallo F, Palu G, Boscaro M (2003) Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol 149: 273-285.
22. Mantero F, Terzolo M, Arnaldi G, Osella G, Masini A, et al. (2000) A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab 85: 637-644.